Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

Toni K. Choueiri Meredith M. Regan Jonathan E. Rosenberg William K. Oh Jessica Clement Angela M. Amato David McDermott Daniel C. Cho Michael B. Atkins Sabina Signoretti

首页> 外文期刊>BJU International >Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

【24h】

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

机译：碳酸酐酶IX和病理特征可预测转移性透明细胞肾细胞癌接受血管内皮生长因子靶向治疗的患者预后

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Study Type – Prognosis (retrospective cohort) Level of Evidence 2b

机译：研究类型–预后（回顾性队列）证据水平2b

著录项

来源
《BJU International》 |2010年第6期|p.772-778|共7页
作者
Toni K. Choueiri Meredith M. Regan Jonathan E. Rosenberg William K. Oh Jessica Clement Angela M. Amato David McDermott Daniel C. Cho Michael B. Atkins Sabina Signoretti;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
renal cell cancer; vascular endothelial growth factor; carbonic anhydrase IX; pathological features;

机译：肾细胞癌;血管内皮生长因子;碳酸酐酶IX;病理特征;

相似文献

外文文献
中文文献
专利

1. Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy. [J] . Choueiri TK, Regan MM, Rosenberg JE, BJU international . 2010,第6期

机译：碳酸酐酶IX和病理特征可作为接受血管内皮生长因子靶向治疗的转移性透明细胞肾细胞癌患者预后的指标。
2. Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium [J] . Kaymakcalan Marina D., Xie Wanling, Albiges Laurence, Cancer: A Journal of the American Cancer Society . 2016,第3期

机译：血管内皮生长因子靶向疗法治疗转移性肾细胞癌患者的风险因素和预测毒性相关治疗终止的模型：国际转移性肾细胞癌数据库联合会的结果
3. Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET) [J] . ChoueiriT.K., ChengS., QuA.Q., Urologic oncology . 2013,第8期

机译：碳酸酐酶IX作为接受索拉非尼或安慰剂的转移性透明细胞肾细胞癌患者疗效的潜在生物标志物：肾癌全球评估试验（TARGET）的治疗方法分析
4. Matrix Metalloproteinase-2 and High Vascular Endothelial Growth Factor as Prognostic Markers for Intrahepatic Tumor Recurrence in Hepatocellular Carcinoma Patients Receiving Radiotherapy [C] . Eun-Jung Lee, Jinsil Seong, Yang-Gun Suh, Molecular Medicine TRI-CON. . 2014

机译：基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物，接受放射治疗
5. Identifying Pathologic and Molecular Features that Predict Adverse Clinical Outcomes in Vulvar Squamous Cell Carcinoma. [D] . Holthoff, Emily Ruth. 2016

机译：鉴定可预测外阴鳞状细胞癌不良临床结果的病理和分子特征。
6. Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET) [O] . Toni K. Choueiri, Suchun Cheng, Angela Q. Qu, -1

机译：碳酸酐酶IX如转移性透明细胞肾细胞癌患者的疗效的生物标记物的潜在接受索拉非尼或安慰剂：分析从治疗肾癌全球评价试验方法（TaRGET）
7. Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer [O] . Stewart, Grant D., O'Mahony, Fiach C., Laird, Alexander, 2014

机译：碳酸酐酶9表达随血管内皮生长因子靶向治疗的增加而增加，并预测转移性透明细胞肾癌的预后

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

摘要

著录项

相似文献

相关主题

期刊订阅